logo

For the Inventor, By the Inventor

Groningen, Netherlands

Robert Rosén

This inventor holds 15 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Amo Groningen B.v., Abbott Medical Optics Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Rosén. Retrieved from https://idiyas.com/inventor/robert-rosén

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 100.0


Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal14 out of 185 
 
Amo Groningen B.v.
 patents
silverMedal1 out of 303 
 
Abbott Medical Optics Inc.
 patents

Years Active: 2017-2026

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12521233 - Intraocular lenses that improve peripheral vision (2026-01-13),
2. 12472056 - Ophthalmic devices, system and methods that improve peripheral vision (2025-11-18),
3. 11881310 - Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof (2024-01-23),
4. 11877924 - Ophthalmic devices, system and methods that improve peripheral vision (2024-01-23),
5. 11819401 - Intraocular lenses with customized add power (2023-11-21),
6. 11793626 - Intraocular lenses that improve peripheral vision (2023-10-24),
7. 11707354 - Methods and apparatuses to increase intraocular lenses positional stability (2023-07-25),
8. 11282605 - Intraocular lenses that improve post-surgical spectacle independent and methods of manufacturing thereof (2022-03-22),
9. 11160651 - Intraocular lenses that improve peripheral vision (2021-11-02),
10. 11096778 - Ophthalmic devices, system and methods that improve peripheral vision (2021-08-24),
11. 11000362 - Intraocular lenses with customized add power (2021-05-11),
12. 10588738 - Intraocular lenses that improve peripheral vision (2020-03-17),
13. 10088384 - Apparatus, systems and methods for improving visual outcomes for pseudophakic patients (2018-10-02),
14. 9823163 - Apparatus, systems and methods for improving visual outcomes for pseudophakic patients (2017-11-21),
15. 9561098 - Intraocular lens that matches an image surface to a retinal shape, and method of designing same (2017-02-07),

Title: The Inventor Making Waves in Ophthalmic Innovations: Robert Rosén

Introduction: Robert Rosén, a visionary inventor based in Groningen, NL, has left an indelible mark on the world of ophthalmic innovations with his insatiable drive for progress and groundbreaking inventions.

Latest Patents: With an impressive portfolio of 13 patents, Robert's latest inventions include cutting-edge intraocular lenses that enhance post-surgical spectacle independence and a revolutionary Bayesian model for predicting spectacle independence based on pre-clinical data. Additionally, his work on ophthalmic devices and systems aimed at improving peripheral vision showcases his commitment to enhancing visual outcomes for patients.

Career Highlights: Robert has contributed his expertise to esteemed companies such as AMO Groningen B.V. and Abbott Medical Optics Inc., where he has spearheaded numerous innovative projects and revolutionized the field of ophthalmology.

Collaborations: Throughout his career, Robert has collaborated closely with esteemed colleagues such as Carmen Canovas Vidal and Patricia Ann Piers, whose collective efforts have led to groundbreaking advancements in the ophthalmic industry.

Conclusion: Robert Rosén's relentless pursuit of innovation and his invaluable contributions to ophthalmic advancements have cemented his legacy as a trailblazer in the field of inventors. His visionary work continues to shape the future of ophthalmology and inspire positive change in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…